Atomo Diagnostics
Sydney, Australia· Est.
User‑centred rapid diagnostic platforms that simplify testing and improve accuracy at point‑of‑care.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
User‑centred rapid diagnostic platforms that simplify testing and improve accuracy at point‑of‑care.
Infectious DiseasesSexual HealthWomen’s Health
Technology Platform
User‑centred integrated rapid diagnostic devices that combine sample collection, buffer delivery, and result readout into a single, error‑reducing cartridge.
Opportunities
Expansion into new infectious disease indications and integration of digital health connectivity can drive broader adoption of Atomo’s platforms.
Risk Factors
Regulatory complexity across markets and competition from established diagnostic manufacturers could limit growth if not managed effectively.
Competitive Landscape
Competitors such as Abbott, Roche, and other lateral flow test makers lack Atomo’s integrated, user‑centred design, giving Atomo a differentiation advantage in ease‑of‑use and error reduction.